clinical
FDA funds study on LLMs evaluating AI radiology reports
The FDA awarded Cognita Imaging $1.29M to test if large language models can evaluate AI radiology reports, addressing a key gap in…
Healthcare AI adoption outpaces governance controls
Healthcare AI adoption outpaces governance controls, with 72% of organizations deploying AI tools without IT approval despite 85% claiming full visibility.
FDA tightens human factors rules for medical devices
The FDA’s stricter human factors rules for medical devices now prioritize usability engineering as a core safety requirement, reshaping validation standards for
New Treatment Improves Survival in First-Line Small Cell Lung Cancer
New treatment improves survival in first-line small cell lung cancer with a combination of tarlatamab and durvalumab, showing a significant clinical benefit.
Tozorakimab Reduces COPD Inflammation Across Multiple Pathways
tozorakimab COPD therapy shows significant reduction of inflammation by targeting multiple pathways, offering new hope beyond eosinophil‑focused treatments.
FDA approves Camizestrant for breast cancer with ESR1 mutations
The FDA approves camizestrant for ER-positive, HER2-negative metastatic breast cancer with ESR1 mutations. Learn about this new treatment option and its clinica
Adjunct Antipsychotics Offer Hope for Depression Treatment
Adjunct antipsychotics are emerging as a promising option for treating depression when antidepressants fall short, offering new hope for patients.
New three-stage framework targets early arthritis detection
Learn about a new three-stage framework for early arthritis detection designed to identify psoriatic joint damage before permanent symptoms occur.
FDA Approves New Narcolepsy Treatment
FDA approves new narcolepsy treatment targeting orexin deficiency for narcolepsy type 1 patients.